2002
DOI: 10.1159/000067922
|View full text |Cite
|
Sign up to set email alerts
|

Generation of Recombinant Virus-Like Particles of Human and Non-Human Polyomaviruses in Yeast <i>Saccharomyces cerevisiae</i>

Abstract: Objectives: Non-viral methods of gene transfer have been preferred in gene therapy approaches for several reasons, particularly for their safety, simplicity and convenience in introducing heterologous DNA into cells. Polyomavirus virus-like particles (VLPs) represent a promising carrier for encapsidation of foreign nucleic acids for gene therapy. For the development of such gene delivery systems as well as for providing reagents for improving virus diagnostics, an efficient yeast expression system for the gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
51
1

Year Published

2004
2004
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(58 citation statements)
references
References 32 publications
5
51
1
Order By: Relevance
“…Compared to mammalian polyomaviruses, however, available data indicate marked differences in the structure and assembly of the APV capsid due to (i) the incorporation of a fourth structural protein, VP4, in addition to VP1, VP2, and VP3 (12) and (ii) the missing or inefficient formation of VLP following VP1 expression in insect cells (1) or yeast (35), respectively. In order to investigate the requirements for APV capsid assembly, the APV structural proteins were expressed in CE cells permissive for APV replication, the proteins were localized within the cell, and the conditions for VLP formation were analyzed.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Compared to mammalian polyomaviruses, however, available data indicate marked differences in the structure and assembly of the APV capsid due to (i) the incorporation of a fourth structural protein, VP4, in addition to VP1, VP2, and VP3 (12) and (ii) the missing or inefficient formation of VLP following VP1 expression in insect cells (1) or yeast (35), respectively. In order to investigate the requirements for APV capsid assembly, the APV structural proteins were expressed in CE cells permissive for APV replication, the proteins were localized within the cell, and the conditions for VLP formation were analyzed.…”
Section: Discussionmentioning
confidence: 99%
“…In the case of APV, however, expression of VP1, either alone or after coexpression with VP2 and/or VP3, by recombinant-baculovirus-infected insect cells did not lead to VLP formation (1). Recently, VLP formation has been reported after recombinant expression of VP1 proteins of several polyomaviruses, including APV, in the yeast Saccharomyces cerevisiae (35). In this system, VLP formed by APV VP1 were generated; it was observed, however, that the efficacy of VLP formation was ϳ10-fold lower than that of the mammalian polyomaviruses.…”
mentioning
confidence: 99%
“…After 6 days, a third passage was performed analogously. The cells were harvested and subjected to immunoblotting using a rabbit antiserum directed against APV particles (49) and cross-reacting with VP1 proteins of several other polyomaviruses (44).…”
Section: Methodsmentioning
confidence: 99%
“…The assembly of Vp1 pentamers into icosahedral shells is an intrinsic property of Vp1, since Vp1 alone of SV40 and several other polyomaviruses is sufficient for the formation of capsidlike structures in vitro (53), in Escherichia coli (45), in Saccharomyces cerevisiae (46,55), in insect cells (5,22,36,47,54), and in mammalian cells (15,34). Furthermore, the capsid proteins of polyomaviruses have been implicated, by numerous studies using different experimental systems, in other important functions of viral infection.…”
mentioning
confidence: 99%